Viewing Study NCT04472858


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2025-12-25 @ 10:14 PM
Study NCT ID: NCT04472858
Status: UNKNOWN
Last Update Posted: 2022-11-29
First Post: 2020-07-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CS1001/Donafenib-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View